Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease

Circulation

Volumn 96, Issue 10, 1997, Pages 3346-3352

  Skopicki, Hal A ^a   Abraham, Stephen A ^a   Picard, Michael H ^a   Alpert, Nathaniel M ^a   Fischman, Alan J ^a   Gewirtz, Henry ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood flow; Dobutamine; Ischemia

Indexed keywords

ADENOSINE; DOBUTAMINE;

ADULT; AGED; ARTERY STEAL SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; HYPEREMIA; IMAGE ANALYSIS; INOTROPISM; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030830850     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3346     Document Type: Article

References (21)

1. Krivokapich J, Czernin J, Schelbert H. Dobutamine positron emission tomography: absolute quantification of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol. 1996;28:565-572.
2. Severi S, Underwood R, Mohiaddin RH, Boyd H, Paterni M, Camici P. Dobutamine stress: effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol. 1995;26:1187-1195.
3. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333-2342.
4. Skopicki HA, Abraham SA, Weissman NJ, Mukerjee AK, Alpert NA, Fischman AJ, Picard MH, Gewirtz H. Factors influencing regional myocardial contractile response to inotropic stimulation: analysis in humans with stable ischemic heart disease. Circulation. 1996;94:643-650.
5. Vatner SF, McRitchie RJ, Braunwald EB. Effects of dobutamine on left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs. J Clin Invest. 1974;53:1265-1273.
6. Willerson JT, Hutton I, Watson JT, Platt MR, Templeton GH. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs. Circulation. 1976;53:828-833.
7. 2 consumption in normal human heart: effects of dobutamine. Am J Physiol. 1993;265(Heart Circ Physiol 34):H1884-H1892.
8. Meyer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol. 1976;38:103-108.
9. Gewirtz H, Gross SL, Williams DO, Most AS. Contrasting effects of nifedipine and adenosine on regional flow distribution and metabolism distal to a severe coronary arterial stenosis: observations in sedated, closed-chest domestic swine. Circulation. 1984;69: 1048-1057.
10. Gewirtz H, Fischman AJ, Abraham SA, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol. 1994;23:851-859.
11. Rosenspire KC, Schwaiger M, Magner TJ, Hutchins GD, Sutorik A, Kuhl DE. Metabolic fate of 13-N-ammonia in human and canine blood. J Nucl Med. 1990;31:163-167.
12. Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NA, Fischman AJ. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemie heart disease. Cardiology. 1997;88:62-70.
13. Janier MF, Andre-Fouet X, Landais P, Gregoire MC, Lavenne F, Amaya J, Mercier C, Machecourt J, Cinotti L. Perfusion MVO2 mismatch during inotropic stress in CAD patients with normal contractile function. Am J Physiol. 1996;271(Heart Circ Physiol 40): H59-H67.
14. Bartunek J, Marwick TH, Rodrigues ACT, Vincent M, Van Schuerbeeck E, Sys SU, de Bruyne B. Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol. 1996;27:1429-1436.
15. Segar DS, Ryan T, Sawada SG, Johnson M, Feigenbaum H. Pharmacologically induced myocardial ischemia: a comparison of dobutamine and dipyridamole. J Am Soc Echocardiogr. 1995; 8:9-14.
16. Zhang J, Path G, Chepuri V, Homans DC, Merkle H, Hendrich K, Ugurbil K, Bache RJ, From AHL. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implications with regard to dobutamine stress testing. Am Heart J. 1995;129:330-342.
17. Fung AY, Gallagher KP, Buda AJ. The physiological basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 1987;76: 943-951.
18. Gould KL. Non-invasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacological coronary vasodilation, I: physiological basis and experimental validation. Am J Cardiol. 1978;41:267-278.
19. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation. 1990;81:628-636.
20. 99mTc-MIBI single photon emission computed tomography. Circulation. 1993;87:345-354.
21. Vatner S. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res. 1980;47: 201-207.